Teva to close Sudocrem plant in Dublin, 110 jobs to go Pharmaceutical company Teva is to close it Sudocrem manufacturing plant in Baldoyle in Dublin, with the loss of 110 jobs. Business • 07 May 21
EU Commission opens antitrust probe into Teva Israeli drugmaker is being investigated by EU antitrust regulators who are looking into whether it illegally hindered rivals' access to its multiple sclerosis medicine Copaxone. Business • 04 Mar 21
Berkshire buys Teva, while Apple becomes top investment Warren Buffett's Berkshire Hathaway has disclosed a new stake in generic drugmaker Teva Pharmaceutical Industries. Business • 15 Feb 18
Teva to sell Allergan's generics unit in Ireland Teva Pharmaceutical Industries is to sell Allergan's generics business in the UK and Ireland to India's Intas Pharmaceuticals for £603m. Business • 06 Oct 16
Mylan rejects Teva offer, but leaves door open Mylan has today rejected Teva Pharmaceutical Industries' unsolicited $40 billion takeover offer, but left the door open for talks. Business • 27 Apr 15
Teva makes $40 billion offer for rival Mylan Generic drugmaker Teva Pharmaceutical Industries has proposed buying smaller rival Mylan for $40 billion. Business • 21 Apr 15
Teva pharmaceutical sees revenue grow in Q1 Pharmaceutical group Teva has reported revenues of $5bn for the first three months of 2014; up 2% on the same period of last year. Business • 01 May 14
Teva reports 19% increase in Q2 revenues Teva, a global pharmaceutical company which employs almost 500 people in Ireland, has reported a 19% increase in its second-quarter revenues over the same time … Business • 10 Aug 12
